Work

Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression

Year: 2015

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2015.02.017

Authors: Kaisheng Mao, Fakeng Liu, Xiuju Liu, Fadlo R. Khuri, Adam I. Marcus, Mingsong Li, Wei Zhou

Institutions: Emory University, Nanfang Hospital, Winship Cancer Institute, Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Pro-Oncogenic Role of LKB1 in NSCLC, Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy, Winship Cancer Institute Cancer Center Support Grant

OpenAlex ID: W1986790649

FWCI: 0.437

Cites: 29

Cited by: 14

Related to: 10